Atorvastatin related compound H is a dimeric byproduct arising from the coupling of two Atorvastatin moieties via a methylene bridge, featuring a fluorophenyl substituent, a pyrrole-fused tetrahydrofuran ring, and a hydroxylated lactone core. Its structure retains key pharmacophoric elements of the parent drug but exhibits altered stereochemistry and an additional ester linkage. This impurity is formed during synthetic over-coupling in the final API synthesis step. Serves as an HPLC reference standard for quantifying process-related impurities in Atorvastatin formulations.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1044582 โ | 20 mg | USD 880.00 |
CC(C)C1=C(C(=C(N1CC[C@@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=CC=C4)C(=O)NC5=CC=CC=C5
InChI=1S/C33H33FN2O4/c1-21(2)31-30(33(39)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-27-19-26(37)20-28(38)40-27/h3-16,21,26-27,37H,17-20H2,1-2H3,(H,35,39)/t26-,27-/m1/s1
OUCSEDFVYPBLLF-KAYWLYCHSA-N